Project Grant R25AI181751
Award Date
8/16/24
Completion Date
7/31/29
Dollars Obligated
$367K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
The federal Project Grant award R25AI175017, titled the "Maryland Infection, Immunization, Intervention, and Impact (M4I) Training Program," was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855: Allergy and Infectious Diseases Research. The $337,719 award will establish a structured training program at the University of Maryland, Baltimore (UMB) to inspire and prepare medical students to pursue careers in infectious disease research. The...
The University of Maryland, Baltimore (UMB) was awarded a $352,643 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, titled "Integrated Training Program in Vaccinology (ITP-VAX)", aims to encourage more trainees, particularly underrepresented minorities, to join the field of vaccinology and enable early-career vaccinologists to become independent researchers....
The University of Maryland, Baltimore received a $2,002,422.00 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, titled "Mechanisms of Mucosal and Systemic Immunity to Vaccination and Infection with Enteric Pathogens in Children and Adults", will fund research to further the understanding of protective immunological mechanisms against major...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $340,452 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Puerto Rico Comprehensive Cancer Center. The 5-year grant, which began on August 1, 2024, will establish the Research Education Program on Microbes, Infections, and Cancer (REPMIC) to recruit and train 50 recent college graduates from underrepresented backgrounds in Puerto Rico. REPMIC will provide...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $379,080 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Western University of Health Sciences to support a 2.5-month summer research education program. The program will strategically recruit and train 15 qualified, motivated, and research-oriented participants per year from the university's health professional student population, including those from underrepresented and disadvantaged...
This $595,901 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to expand the understanding of biosynthetic mechanisms for natural antimicrobial peptides (AMPs). The overarching goal is to dissect the mechanisms of a novel biosynthetic gene cluster (BGC) that leads to AMP production, with a focus on ascribing roles of the BGC components in both the biosynthetic events yielding...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $142,599 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas at San Antonio (UTSA). The goal of this 5-year grant is to recruit, train, and graduate a diverse group of doctoral students in multidisciplinary areas of molecular microbiology and immunology research at UTSA, a Hispanic-serving research institution. Key objectives include providing...
This federal Project Grant award of $578,093 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research into the immunobiology of a novel human DAMP receptor and its murine homolog, including their ligand. The award was made to the University of Massachusetts Medical School (UMass Medical), a prominent research institution and medical school experienced in securing federal grants and contracts....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $479,204 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore. The 2-year award, effective from July 2024 through May 2026, will support research to identify parasite variant surface antigens associated with severe malaria in Zambian children and adults. The project aims to sequence variant surface antigen transcripts from severe malaria cases and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $328,482 Project Grant through the Allergy and Infectious Diseases Research program (CFDA 93.855) to Idaho State University (ISU) to create the ISU Bridges to Research Careers (BRC) program. The BRC program aims to develop a pathway to biomedical careers for underrepresented undergraduate students by providing a mentoring program, a bacteriophage discovery and bioinformatics course, and a biomedical research network to...